Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

about

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care

P2860

Q55432750-3EB07F9D-9DB0-4F6B-BB00-36431BAFBB89 Q57777292-8C731833-FB5B-43EE-B729-87160DD58D24

P2860

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q47159721

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@en

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@nl

type

Item

label

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@en

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@nl

prefLabel

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@en

Efficacy and safety of tiotrop ...... atic review and meta-analysis.

@nl

P1476

Efficacy and safety of tiotrop ...... matic review and meta-analysis

@en

P2093

Julio Ancochea

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cochrane Database of Systematic Reviews

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Efficacy of tiotropium-olodaterol fixed-dose combination in COPD

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.

Tiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysis.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

P2888

s12931-017-0683-x

P304

196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1186/S12931-017-0683-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerard Urrútia

Marc Miravitlles

Alexander G Mathioudakis

P577

2017-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092982027

http://www.w3.org/2001/XMLSchema#string

P698

29178871

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

mechanism of action

aza compounds

P932

5702233

http://www.w3.org/2001/XMLSchema#string

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

about

P2860

P2860

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932